What is Health P.E.I. doing to bring doctors to the province? Not enough, say some MLAs - CBC

NorthYukon MLAs are expected to discuss affordability, the rising cost of living, and other items related to energy, health, mining and more over the next couple of months after the Legislature's fall sitting begins on Monday. Fall sitting of Yukon Legislative Assembly gets underway MondayDana Hatherly · CBC News · Posted: Oct 02, 2026 7:00 AM EDT | Last Updated: October 2Listen to this articleEstimated 5 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Official Opposition Leader Kate White of the NDP says she plans to press the government on many things during the upcoming fall sitting of the Legislative Assembly, including things such as health care, mining roads and hunting outfitters. (Dana Hatherly/CBC)Keeping the heat and lights on, the price of gas and groceries, and housing rates are top of mind for many Yukoners these days, as the weather turns colder. Yukon MLAs are expected to discuss affordability, the rising cost of living, and other items related to energy, health, mining and more over the next couple of months.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.